Novo NordiskNovo to present new CagriSema and Wegovy® data at ObesityWeek® 2026, including data on treatment experience with Wegovy® pill in the real world
About this email
Captured Announcement
Novo Nordisk announces 26 abstracts presenting new clinical and real-world data for CagriSema and Wegovy at ObesityWeek 2026.
Top-aligned brand logo followed by a plain text-heavy corporate press release with bulleted highlights, detailed trial session schedules, contact tables, and references.
Color palette
Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.
